LOADING
Comparing Microsoft Corporation (MSFT) and AbbVie Inc (ABBV) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MSFT | ABBV |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $2.94T | $388.4B |
| P/E Ratio | 24.8 | 92.7 |
| Forward P/E | 21.0 | 15.1 |
| PEG Ratio | 1.31 | 0.52 |
| EPS | $15.98 | $2.37 |
| Revenue Growth (YoY) | 16.7% | 10.0% |
| Profit Margin | 39.0% | 6.9% |
| Return on Equity | 34.4% | 62.3% |
| Dividend Yield | 0.87% | 2.95% |
| Beta | 1.11 | 0.33 |
| 52-Week High | $552.24 | $241.12 |
| 52-Week Low | $342.17 | $159.05 |
| Volume | -- | -- |
Microsoft Corporation is the larger company by market capitalization. Microsoft Corporation trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. AbbVie Inc offers a higher dividend yield for income investors. Microsoft Corporation has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.